Clinical Trials Browser

Recurrence × Dasatinib × Breast × Clear all

NCT00371345 2011-04-26

Study of Dasatinib (BMS-354825) in Patients With Advanced Estrogen/Progesterone Receptor-positive (ER+/PR+) or Her2/Neu-positive (Her2/Neu+)Breast Cancer

Phase 2 Completed

92 enrolled 27 charts

Breast Neoplasms, Neoplasm Metastasis, Recurrence